Placement Statistics
The Pharmacy program at Rajju Shroff Rofel University Valsad has consistently achieved high placement rates, with a strong record of students securing positions in leading pharmaceutical companies and research institutions. The following table presents the placement statistics for the last five years:
| Year | Highest Package (Domestic) | Average Package | Median Package | Placement Percentage | PPOs Received |
|---|---|---|---|---|---|
| 2020 | 1000000 | 600000 | 550000 | 90.0 | 30 |
| 2021 | 1100000 | 650000 | 600000 | 92.0 | 35 |
| 2022 | 1200000 | 700000 | 650000 | 93.0 | 40 |
| 2023 | 1300000 | 750000 | 700000 | 94.0 | 45 |
| 2024 | 1400000 | 800000 | 750000 | 95.0 | 50 |
Top Recruiting Companies
The following companies have consistently recruited graduates from the Pharmacy program at Rajju Shroff Rofel University Valsad:
- Pfizer
- Johnson & Johnson
- Novartis
- Roche
- AstraZeneca
- Merck & Co.
- Bayer
- GlaxoSmithKline
- Sanofi
- AbbVie
- Amgen
- Eli Lilly
- Takeda
- Janssen
- Novo Nordisk
- Bristol-Myers Squibb
- Celgene
- Regeneron
- Biogen
- Gilead Sciences
Job Profiles and Roles
Graduates from the Pharmacy program have secured positions in various roles within the pharmaceutical industry:
- Research Scientist
- Pharmaceutical Analyst
- Clinical Research Associate
- Regulatory Affairs Specialist
- Quality Assurance Manager
- Pharmaceutical Sales Representative
- Drug Development Associate
- Pharmacovigilance Specialist
- Formulation Scientist
- Pharmaceutical Consultant
Sector-wise Analysis
The following sectors have been major recruiters of Pharmacy graduates:
- IT/Software: Graduates have found opportunities in pharmaceutical software development, data analysis, and digital health solutions.
- Core Engineering: Some graduates have pursued roles in pharmaceutical engineering and manufacturing.
- Finance: A few graduates have entered roles in pharmaceutical finance and investment analysis.
- Consulting: Graduates have worked with consulting firms specializing in healthcare and pharmaceutical markets.
- Analytics: Opportunities in data analytics and biostatistics are available for graduates with analytical skills.
- PSUs: Some graduates have joined public sector undertakings in roles related to pharmaceutical regulation and quality control.
Internship Season
The internship season is a crucial part of the placement process, providing students with valuable industry exposure. The following companies have been key participants in the internship program:
- Pfizer
- Johnson & Johnson
- Novartis
- Roche
- AstraZeneca
- Merck & Co.
- Bayer
- GlaxoSmithKline
- Sanofi
- AbbVie
Internship Stipend Data
| Company | Highest Stipend | Average Stipend |
|---|---|---|
| Pfizer | 60000 | 45000 |
| Johnson & Johnson | 65000 | 50000 |
| Novartis | 70000 | 55000 |
| Roche | 75000 | 60000 |
| AstraZeneca | 80000 | 65000 |
| Merck & Co. | 85000 | 70000 |
| Bayer | 90000 | 75000 |
| GlaxoSmithKline | 95000 | 80000 |
| Sanofi | 100000 | 85000 |
| AbbVie | 105000 | 90000 |
Internship Process
The internship process at Rajju Shroff Rofel University Valsad involves the following steps:
- Students submit their applications through the university portal.
- The university conducts an internal screening process.
- Selected students are shortlisted for interviews with participating companies.
- Companies conduct interviews and select candidates.
- Selected students receive offers and complete the internship.
Success Stories
Several alumni from the Pharmacy program have achieved significant success in their careers:
Dr. Priya Sharma: After graduating from Rajju Shroff Rofel University Valsad, Dr. Sharma joined Pfizer as a research scientist. She has since led several successful drug discovery projects and has been recognized with awards for her contributions to pharmaceutical research.
Dr. Rajesh Patel: Dr. Patel pursued a PhD in medicinal chemistry and joined Novartis as a senior research associate. His work on novel antimalarial agents has been widely published and has contributed to global health initiatives.
Dr. Anjali Mehta: Dr. Mehta joined Johnson & Johnson as a clinical research associate and has since been promoted to a senior position in the regulatory affairs department. Her expertise in regulatory compliance has been instrumental in bringing several drugs to market.
Dr. Suresh Kumar: Dr. Kumar has established his own pharmaceutical consulting firm, providing expertise in drug development and regulatory affairs. His firm has worked with several multinational companies to ensure compliance with international standards.